Jason Bednar
Stock Analyst at Piper Sandler
(3.58)
# 674
Out of 4,610 analysts
138
Total ratings
53.4%
Success rate
3.98%
Average return
Main Sectors:
Stocks Rated by Jason Bednar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALGN Align Technology | Maintains: Overweight | $315 | $241.35 | +30.52% | 25 | Sep 13, 2024 | |
| MMSI Merit Medical Systems | Reiterates: Overweight | $100 → $110 | $95.63 | +15.03% | 7 | Sep 9, 2024 | |
| COO The Cooper Companies | Reiterates: Overweight | $115 → $120 | $105.92 | +13.29% | 11 | Aug 29, 2024 | |
| DRTS Alpha Tau Medical | Reiterates: Overweight | $7 | $2.28 | +207.02% | 5 | Aug 15, 2024 | |
| KRMD KORU Medical Systems | Maintains: Overweight | $2.5 → $3 | $2.62 | +14.50% | 4 | Aug 8, 2024 | |
| XAIR Beyond Air | Maintains: Overweight | $3.5 → $1 | $0.42 | +136.97% | 3 | Aug 7, 2024 | |
| MASI Masimo | Maintains: Overweight | $160 → $165 | $138.83 | +18.85% | 11 | Aug 7, 2024 | |
| LUNG Pulmonx | Maintains: Overweight | $14 → $12 | $7.30 | +64.38% | 10 | Aug 1, 2024 | |
| NVST Envista Holdings | Maintains: Neutral | $18 → $16 | $18.83 | -15.03% | 9 | Jul 30, 2024 | |
| HSIC Henry Schein | Reiterates: Overweight | $86 | $70.56 | +21.88% | 6 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $13 | $15.80 | -17.72% | 1 | May 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $220 → $225 | $231.02 | -2.61% | 7 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $35 → $32 | $25.22 | +26.88% | 7 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $25 → $28 | $14.72 | +90.22% | 8 | Apr 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $6 → $7 | $2.00 | +250.00% | 4 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $34 → $28 | $20.60 | +35.92% | 7 | Feb 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $310 → $372 | $481.95 | -22.81% | 4 | Jan 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $14 → $9 | $2.64 | +240.91% | 2 | Nov 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $305 → $280 | $238.22 | +17.54% | 6 | Nov 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $95 | $91.42 | +3.92% | 1 | Apr 19, 2023 |
Align Technology
Sep 13, 2024
Maintains: Overweight
Price Target: $315
Current: $241.35
Upside: +30.52%
Merit Medical Systems
Sep 9, 2024
Reiterates: Overweight
Price Target: $100 → $110
Current: $95.63
Upside: +15.03%
The Cooper Companies
Aug 29, 2024
Reiterates: Overweight
Price Target: $115 → $120
Current: $105.92
Upside: +13.29%
Alpha Tau Medical
Aug 15, 2024
Reiterates: Overweight
Price Target: $7
Current: $2.28
Upside: +207.02%
KORU Medical Systems
Aug 8, 2024
Maintains: Overweight
Price Target: $2.5 → $3
Current: $2.62
Upside: +14.50%
Beyond Air
Aug 7, 2024
Maintains: Overweight
Price Target: $3.5 → $1
Current: $0.42
Upside: +136.97%
Masimo
Aug 7, 2024
Maintains: Overweight
Price Target: $160 → $165
Current: $138.83
Upside: +18.85%
Pulmonx
Aug 1, 2024
Maintains: Overweight
Price Target: $14 → $12
Current: $7.30
Upside: +64.38%
Envista Holdings
Jul 30, 2024
Maintains: Neutral
Price Target: $18 → $16
Current: $18.83
Upside: -15.03%
Henry Schein
Jun 21, 2024
Reiterates: Overweight
Price Target: $86
Current: $70.56
Upside: +21.88%
May 21, 2024
Initiates: Neutral
Price Target: $13
Current: $15.80
Upside: -17.72%
May 10, 2024
Reiterates: Neutral
Price Target: $220 → $225
Current: $231.02
Upside: -2.61%
May 3, 2024
Reiterates: Neutral
Price Target: $35 → $32
Current: $25.22
Upside: +26.88%
Apr 10, 2024
Reiterates: Overweight
Price Target: $25 → $28
Current: $14.72
Upside: +90.22%
Mar 7, 2024
Maintains: Overweight
Price Target: $6 → $7
Current: $2.00
Upside: +250.00%
Feb 29, 2024
Downgrades: Neutral
Price Target: $34 → $28
Current: $20.60
Upside: +35.92%
Jan 3, 2024
Maintains: Outperform
Price Target: $310 → $372
Current: $481.95
Upside: -22.81%
Nov 10, 2023
Maintains: Overweight
Price Target: $14 → $9
Current: $2.64
Upside: +240.91%
Nov 10, 2023
Maintains: Overweight
Price Target: $305 → $280
Current: $238.22
Upside: +17.54%
Apr 19, 2023
Initiates: Overweight
Price Target: $95
Current: $91.42
Upside: +3.92%